LANZAFAME, Massimiliano
LANZAFAME, Massimiliano
DIPARTIMENTO DI DIAGNOSTICA E SANITA' PUBBLICA
'High' antiretroviral deintensification strategy and cellular HIV DNA levels
2020-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Vincenzi, Marcello; Vecchi, Marta; Luise, Dora; Diani, Erica; Gibellini, Davide
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes
2021-01-01 Magrinelli, Francesca; Mariotto, Sara; Nadali, Gianpaolo; Todeschini, Giuseppe; Lanzafame, Massimiliano; Cavallaro, Tiziana; Monaco, Salvatore; Ferrari, Sergio
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report.
2003-01-01 Faggian, Federica; Lattuada, Emanuela; Lanzafame, Massimiliano; Trevenzoli, Marco; Cattelan, Am; Concia, Ercole
Antiretroviral therapy in low-resource settings
2010-01-01 Cainelli, F; Lanzafame, Massimiliano; Vento, S.
Benign acute viral myositis in African migrants: a clinical, serological and pathological study.
2019-01-01 Pancheri, Elia; Lanzafame, Massimiliano; Zamò, Alberto; Angheben, Andrea; Sartoris, Silvia; Zorzi, Antonella; Boaretti, Marzia; Signoretto, Caterina; Guglielmi, Valeria; Ferrari, Sergio; Tonin, Paola; Vattemi, Gaetano
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital
2014-01-01 Costa, E; Biasi, V; Concia, Ercole; Jommi, C; Lattuada, E; Manfr130, S; Venturini, F; Lanzafame, Massimiliano
Can we really identify HIV-1 long-term nonprogressors?
2004-01-01 Vento, Sandro; Lanzafame, Massimiliano; Marina, Malena; Tositti, Giulia; Cainelli, Francesca; Concia, Ercole; Giorgio, Masiero
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection.
1996-01-01 Soldani, Fabio; Lanzafame, Massimiliano; Allegranzi, Benedetta; Bonora, Stefano; Tessari, Gianpaolo; DI PERRI, Giovanni; Concia, Ercole
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials
2018-01-01 Nicole', Stefano; Lanzafame, M; Cucchetto, Giulia; Rigo, F; Lattuada, E; Concia, E
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose
2014-01-01 Lanzafame, Massimiliano; Bonora, S; Lattuada, E; Calcagno, A; Di Perri, G; Concia, Ercole
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption.
2007-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Gottardi, Martina; Antolini, Dario; Concia, Ercole; Vento, Sandro
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature
2017-01-01 Chiesi, Sheila; Piacentini, Daniela; Salerno, NICOLA DUCCIO; Luise, Dora; Peracchi, Marta; Concia, Ercole; Cazzadori, Angelo Antonio; Piovan, Enrico; Lanzafame, Massimiliano
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient
2017-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Nicole', Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients
2019-01-01 Rizzardo, Sebastiano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vincenzi, Marcello; Tacconelli, Evelina; Vento, Sandro
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life
2018-01-01 Lattuada, Emanuela; Lanzafame, Massimiliano; Nicolè, Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load
2016-01-01 Lanzafame, Massimiliano; Gibellini, Davide; Lattuada, Emanuela; Signoretto, Caterina; Mazzi, Romualdo; Concia, Ercole; Vento, Sandro
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up
2017-01-01 Lanzafame, Massimiliano; Nicole', Stefano; Gibellini, Davide; Lattuada, Emanuela; Cucchetto, Giulia; Rigo, Fabio; Diani, Erica; Concia, Ercole; Vento, Sandro
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients
2017-01-01 Rigo, F; Cucchetto, G; Lanzafame, Massimiliano; Nicolè, S; Lattuada, Emanuela; Concia, Ercole; Vento, Sandro
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up
2014-01-01 Lanzafame, Massimiliano; Lattuada, Emanuela; Cucchetto, Giulia; Concia, Ercole; Vento, S.
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients
2019-01-01 Nicolè, Stefano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vecchi, Marta; Tacconelli, Evelina; Vento, Sandro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 'High' antiretroviral deintensification strategy and cellular HIV DNA levels | 1-gen-2020 | Lanzafame, Massimiliano; Lattuada, Emanuela; Vincenzi, Marcello; Vecchi, Marta; Luise, Dora; Diani, Erica; Gibellini, Davide | |
| A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes | 1-gen-2021 | Magrinelli, Francesca; Mariotto, Sara; Nadali, Gianpaolo; Todeschini, Giuseppe; Lanzafame, Massimiliano; Cavallaro, Tiziana; Monaco, Salvatore; Ferrari, Sergio | |
| Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. | 1-gen-2003 | Faggian, Federica; Lattuada, Emanuela; Lanzafame, Massimiliano; Trevenzoli, Marco; Cattelan, Am; Concia, Ercole | |
| Antiretroviral therapy in low-resource settings | 1-gen-2010 | Cainelli, F; Lanzafame, Massimiliano; Vento, S. | |
| Benign acute viral myositis in African migrants: a clinical, serological and pathological study. | 1-gen-2019 | Pancheri, Elia; Lanzafame, Massimiliano; Zamò, Alberto; Angheben, Andrea; Sartoris, Silvia; Zorzi, Antonella; Boaretti, Marzia; Signoretto, Caterina; Guglielmi, Valeria; Ferrari, Sergio; Tonin, Paola; Vattemi, Gaetano | |
| Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital | 1-gen-2014 | Costa, E; Biasi, V; Concia, Ercole; Jommi, C; Lattuada, E; Manfr130, S; Venturini, F; Lanzafame, Massimiliano | |
| Can we really identify HIV-1 long-term nonprogressors? | 1-gen-2004 | Vento, Sandro; Lanzafame, Massimiliano; Marina, Malena; Tositti, Giulia; Cainelli, Francesca; Concia, Ercole; Giorgio, Masiero | |
| Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection. | 1-gen-1996 | Soldani, Fabio; Lanzafame, Massimiliano; Allegranzi, Benedetta; Bonora, Stefano; Tessari, Gianpaolo; DI PERRI, Giovanni; Concia, Ercole | |
| Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials | 1-gen-2018 | Nicole', Stefano; Lanzafame, M; Cucchetto, Giulia; Rigo, F; Lattuada, E; Concia, E | |
| Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose | 1-gen-2014 | Lanzafame, Massimiliano; Bonora, S; Lattuada, E; Calcagno, A; Di Perri, G; Concia, Ercole | |
| Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. | 1-gen-2007 | Lanzafame, Massimiliano; Lattuada, Emanuela; Gottardi, Martina; Antolini, Dario; Concia, Ercole; Vento, Sandro | |
| Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature | 1-gen-2017 | Chiesi, Sheila; Piacentini, Daniela; Salerno, NICOLA DUCCIO; Luise, Dora; Peracchi, Marta; Concia, Ercole; Cazzadori, Angelo Antonio; Piovan, Enrico; Lanzafame, Massimiliano | |
| Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient | 1-gen-2017 | Lanzafame, Massimiliano; Lattuada, Emanuela; Nicole', Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro | |
| Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients | 1-gen-2019 | Rizzardo, Sebastiano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vincenzi, Marcello; Tacconelli, Evelina; Vento, Sandro | |
| Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life | 1-gen-2018 | Lattuada, Emanuela; Lanzafame, Massimiliano; Nicolè, Stefano; Rigo, Fabio; Cucchetto, Giulia; Concia, Ercole; Vento, Sandro | |
| Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load | 1-gen-2016 | Lanzafame, Massimiliano; Gibellini, Davide; Lattuada, Emanuela; Signoretto, Caterina; Mazzi, Romualdo; Concia, Ercole; Vento, Sandro | |
| Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up | 1-gen-2017 | Lanzafame, Massimiliano; Nicole', Stefano; Gibellini, Davide; Lattuada, Emanuela; Cucchetto, Giulia; Rigo, Fabio; Diani, Erica; Concia, Ercole; Vento, Sandro | |
| Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients | 1-gen-2017 | Rigo, F; Cucchetto, G; Lanzafame, Massimiliano; Nicolè, S; Lattuada, Emanuela; Concia, Ercole; Vento, Sandro | |
| Efavirenz dose reduction in HIV-infected patients: a long-term follow-up | 1-gen-2014 | Lanzafame, Massimiliano; Lattuada, Emanuela; Cucchetto, Giulia; Concia, Ercole; Vento, S. | |
| Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients | 1-gen-2019 | Nicolè, Stefano; Lanzafame, Massimiliano; Lattuada, Emanuela; Luise, Dora; Vecchi, Marta; Tacconelli, Evelina; Vento, Sandro |